ANI PHARMACEUTICALS INC

ANIPCIK 0001023024 · Every Form 4 filed by insiders at this issuer.

Filings

Latest Mar 25, 2024

Unique insiders

Showing

38 of 38

Page 1

Top insiders

Most active reporters at ANI PHARMACEUTICALS INC

Name	Roles	Filings
Shanmugam Muthusamy	OfficerDirector	6
Cook Meredith	Officer	5
Mutz Christopher	Officer	5
CAREY STEPHEN P.	Officer	4
Gutwerg Ori	Officer	4
Lalwani Nikhil	OfficerDirector	4
Marken James G.	Officer	4
Gassert Chad	Officer	3
Davis Krista	Officer	2
Pera Antonio R	Director	1

All filings

38 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Mar 25, 2024	Marken James G. SVP OPS & PROD DEV	FTax	3,653	$69.58	$254,176
Mar 25, 2024	CAREY STEPHEN P. SVP & CFO	FTax	6,210	$69.58	$432,092
Mar 25, 2024	Lalwani Nikhil PRESIDENT & CEO · Director	FTax	17,455	$69.58	$1,214,519
Mar 13, 2024	Gassert Chad SVP - CORP. DEV. & STRATEGY	SSale	20,000	$65.81	$1,316,200
Mar 13, 2024	Cook Meredith SR. VP, GENERAL COUNSEL & SEC.	SSale	250	$66.54	$16,635
Mar 11, 2024	CAREY STEPHEN P. SVP & CFO	SSale	7,787	$65.55	$510,438
Mar 11, 2024	Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · Director	SSale	10,000	$67.17	$671,700
Mar 8, 2024	Lalwani Nikhil PRESIDENT & CEO · Director	SSale	28,965	$65.52	$1,897,787
Mar 7, 2024	Marken James G. SVP OPS & PROD DEV	SSale	24,338	$66.37	$1,615,313
Mar 7, 2024	Gutwerg Ori SVP, GENERICS	FTax	2,494	$66.71	$166,375
Mar 7, 2024	Mutz Christopher HEAD OF RARE DISEASE	FTax	2,110	$66.71	$140,758
Mar 7, 2024	Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · Director	SSale	15,085	$66.35	$1,000,890
Mar 6, 2024	Pera Antonio R Director	SSale	7,000	$65.20	$456,400
Mar 6, 2024	Mutz Christopher HEAD OF RARE DISEASE	SSale	5,000	$66.00	$330,000
Mar 1, 2024	Marken James G. SVP OPS & PROD DEV	FTax	1,058	$67.67	$71,595
Mar 1, 2024	CAREY STEPHEN P. SVP & CFO	FTax	1,914	$67.67	$129,520
Mar 1, 2024	Lalwani Nikhil PRESIDENT & CEO · Director	FTax	10,014	$67.67	$677,647
Mar 1, 2024	Gutwerg Ori SVP, GENERICS	FTax	1,570	$67.67	$106,242
Mar 1, 2024	Mutz Christopher HEAD OF RARE DISEASE	FTax	1,275	$67.67	$86,279
Mar 1, 2024	Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · Director	FTax	1,122	$67.67	$75,926
Mar 1, 2024	Gassert Chad SVP - CORP. DEV. & STRATEGY	FTax	1,635	$67.67	$110,640
Mar 1, 2024	Cook Meredith SR. VP, GENERAL COUNSEL & SEC.	FTax	1,173	$67.67	$79,377
Mar 1, 2024	Davis Krista SVP, CHIEF HR OFFICER	FTax	1,173	$67.67	$79,377
Feb 20, 2024	Gutwerg Ori SVP, GENERICS	FTax	1,244	$57.55	$71,592
Feb 20, 2024	Mutz Christopher HEAD OF RARE DISEASE	FTax	1,261	$57.55	$72,571
Feb 16, 2024	Marken James G. SVP OPS & PROD DEV	AGrant	10,066	$0.00	$0
Feb 16, 2024	CAREY STEPHEN P. SVP & CFO	AGrant	21,474	$0.00	$0
Feb 16, 2024	Lalwani Nikhil PRESIDENT & CEO · Director	AGrant	80,530	$0.00	$0
Feb 16, 2024	Gutwerg Ori SVP, GENERICS	AGrant	14,763	$0.00	$0
Feb 16, 2024	Mutz Christopher HEAD OF RARE DISEASE	AGrant	18,790	$0.00	$0
Feb 16, 2024	Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · Director	AGrant	13,421	$0.00	$0
Feb 16, 2024	Gassert Chad SVP - CORP. DEV. & STRATEGY	AGrant	13,421	$0.00	$0
Feb 16, 2024	Cook Meredith SR. VP, GENERAL COUNSEL & SEC.	AGrant	14,763	$0.00	$0
Feb 16, 2024	Davis Krista SVP, CHIEF HR OFFICER	AGrant	12,079	$0.00	$0
Feb 13, 2024	Cook Meredith SR. VP, GENERAL COUNSEL & SEC.	SSale	250	$56.04	$14,010
Jan 23, 2024	Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · Director	SSale	15,000	$56.44	$846,600
Jan 18, 2024	Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · Director	SSale	10,000	$55.11	$551,100
Jan 16, 2024	Cook Meredith SR. VP, GENERAL COUNSEL & SEC.	SSale	250	$56.43	$14,108

Showing 1–38 of 38

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.